Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Temporomandibular Disorder: early-phase trial registry
2 of 4 indexed Temporomandibular Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Temporomandibular Disorder: 4 US clinical trials tracked, 2 recruiting.
Temporomandibular Disorder is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Maryland, Baltimore, running 2 of these trials.
Enrollment posture brief
Registry condition temporomandibular-disorder
OPEN 2 | RECR 50% | LATE 0 | EARLY 2 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Temporomandibular Disorder lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Temporomandibular Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Temporomandibular Disorder is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
K23- Physical Self Regulation vs Placebo
Ian Boggero, PhD
NCT06357702
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
University of Maryland, Baltimore
NCT06214923
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
University of Maryland, Baltimore
NCT04851301
Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder
Indiana University
NCT04884763
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Temporomandibular Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Temporomandibular Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Temporomandibular Disorder page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Temporomandibular Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Maryland, Baltimore sponsors the most Temporomandibular Disorder trials on record, review their full trial history before evaluating a specific study. See University of Maryland, Baltimore's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Temporomandibular Disorder condition card totals 4 registered trials; most-linked intervention Placebo (EREN-P) s.c. administered every four weeks for a total of five treatments; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.